COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021
Volume: 57, Pages: 103335 - 103335
Published: Jan 1, 2022
Abstract
Background: Despite investigations on the effect of disease modifying therapies (DMTs) used in multiple sclerosis (MS) on coronavirus disease 2019 (COVID-19); there are still controversies.Objective: We designed this study to evaluate the epidemiological features of covid-19 in a large sample of people with MS (pwMS) in Isfahan, Iran, as well as the association between DMTs, risk of COVID-19 infection and hospitalization.Methods: In an...
Paper Details
Title
COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021
Published Date
Jan 1, 2022
Volume
57
Pages
103335 - 103335
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History